We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ZRSEF market cap is 534.74M. The company's latest EPS is CHF -8.5810 and P/E is -14.40.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 1.4B | 1.49B | 1.73B | 1.63B | 976.37M |
| Operating Income | -45.67M | -120.93M | -202.33M | -141.77M | -83.94M |
| Net Income | -52.36M | -135.7M | -225.74M | -171.12M | -117.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 991.73M | 1.28B | 1.27B | 1.1B | 866.42M |
| Total Liabilities | 586.18M | 746.74M | 784.29M | 748.67M | 435.89M |
| Total Equity | 405.54M | 531.74M | 484.92M | 350.78M | 430.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -82.57M | -67.51M | -130.63M | -97.29M | -87.42M |
| Investing | -143.18M | -199.86M | -67.33M | -89.77M | 219.82M |
| Financing | 200.19M | 363.25M | 179.72M | 39.11M | -202.63M |
| Market Cap | 534.74M |
| Price to Earnings Ratio | -14.40 |
| Price to Sales Ratio | 1.73 |
| Price to Cash Ratio | 31.34 |
| Price to Book Ratio | 3.93 |
| Dividend Yield | - |
| Shares Outstanding | 13.7M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 2 |
| 52 Week Change | -51.71% |
| 52 Week High | 108.05 |
| 52 Week Low | 35.5459 |
| Spread (Intraday) | 152.84k (100%) |
| Company Name | DocMorris AG (PK) |
| Address |
walzmuehlestrasse 49 frauenfeld 8500 |
| Website | https://www.zurrosegroup.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
